“Buy” - “Sell” 6-year average, %/year (annualized from 3-month gains): | +14.5% |
These are annualized average 3-month performance results for annual and quarterly financial statements dates falling into a particular calendar year. The performance for the last in the calendar year statement is actually measured in the following year, but is “drawn back” for inclusion into the calendar year under consideration.
The valuation model performance presented on the chart consists of two lines. The green line shows the actual average performance in different years of all stocks in the stock index that were rated by our valuation model (called “Intrinsic value” in the stock table below) as “buy” and “strong buy”. The red line - those rated as “sell” and “strong sell”.
Such performance would be reflective of the performance of two portfolios: one including only “buy” stocks in the index, and another consisting only of sell stocks, with investment decisions taken upon publishing of financial statements for each individual stock in the index.
Though these performances are actual, they are the product of backtesting. That means that if we tweak our stock valuation model, the past performance also changes. The benefit of this is that you always see actual part performance of the current version of the stock valuation model.
Ticker | Company Name | Stock price, $ | Up/down potential, % | ||
---|---|---|---|---|---|
Intrinsic value | Graham -Dodd | Graham formula | |||
A | Agilent Technologies, Inc | 125.02 | -84 | -83 | -34 |
ABBV | AbbVie Inc. | 108.69 | -88 | -82 | -120 |
ABC | AmerisourceBergen Corpora | 105.20 | n/a | n/a | n/a |
ABMD | ABIOMED, Inc. | 323.78 | premium content | ||
ABT | Abbott Laboratories | 122.38 | premium content | ||
AGN | Allergan Plc | 0.00 | n/a | n/a | n/a |
ALGN | Align Technology, Inc. | 573.26 | premium content | ||
ALXN | Alexion Pharmaceuticals, | 154.49 | premium content | ||
AMGN | Amgen Inc. | 229.99 | premium content | ||
ANTM | Anthem, Inc. | 305.79 | premium content | ||
BAX | Baxter International Inc. | 78.51 | premium content | ||
BDX | Becton, Dickinson and Com | 246.71 | n/a | n/a | n/a |
BIIB | Biogen Inc. | 282.74 | premium content | ||
BMY | Bristol Myers Squibb Comp | 62.59 | premium content | ||
BSX | Boston Scientific Corpora | 39.53 | premium content | ||
CAH | Cardinal Health, Inc. | 52.55 | premium content | ||
CERN | Cerner Corporation | 70.29 | premium content | ||
CI | Cigna Corporation | 214.94 | premium content | ||
CNC | Centene Corporation | 59.35 | premium content | ||
COO | The Cooper Companies, Inc | 392.57 | premium content | ||
CVS | CVS Health Corporation | 70.40 | premium content | ||
DGX | Quest Diagnostics Incorpo | 115.74 | premium content | ||
DHR | Danaher Corporation | 223.00 | premium content | ||
DVA | DaVita Inc. | 102.89 | premium content | ||
EW | Edwards Lifesciences Corp | 84.45 | premium content | ||
GILD | Gilead Sciences, Inc. | 63.71 | premium content | ||
HCA | HCA Healthcare, Inc. | 175.43 | premium content | ||
HOLX | Hologic, Inc. | 75.15 | premium content | ||
HSIC | Henry Schein, Inc. | 65.01 | premium content | ||
HUM | Humana Inc. | 381.40 | premium content |
Ticker | Company Name | Stock price, $ | Up/down potential, % | ||
---|---|---|---|---|---|
Intrinsic value | Graham -Dodd | Graham formula | |||
IDXX | IDEXX Laboratories, Inc. | 532.88 | -88 | -96 | -73 |
ILMN | Illumina, Inc. | 461.05 | -75 | -87 | -31 |
INCY | Incyte Corporation | 80.61 | -66 | -74 | -15 |
IQV | IQVIA Holdings Inc. | 194.59 | premium content | ||
ISRG | Intuitive Surgical, Inc. | 758.71 | premium content | ||
JNJ | Johnson & Johnson | 162.59 | premium content | ||
LH | Laboratory Corporation of | 244.50 | premium content | ||
LLY | Eli Lilly and Company | 204.52 | premium content | ||
MCK | McKesson Corporation | 181.29 | premium content | ||
MDT | Medtronic PLC | 118.74 | premium content | ||
MRK | Merck & Co., Inc. | 74.57 | premium content | ||
MTD | Mettler-Toledo Internatio | 1127.60 | premium content | ||
MYL | Mylan NV Ord Shs | 0.00 | n/a | n/a | n/a |
PFE | Pfizer Inc. | 33.75 | premium content | ||
PKI | PerkinElmer, Inc. | 128.78 | premium content | ||
PRGO | Perrigo Company plc | 41.66 | premium content | ||
REGN | Regeneron Pharmaceuticals | 458.60 | premium content | ||
RMD | ResMed Inc. | 200.97 | premium content | ||
STE | STERIS plc | 173.11 | premium content | ||
SYK | Stryker Corporation | 248.82 | premium content | ||
TFX | Teleflex Incorporated | 400.39 | premium content | ||
TMO | Thermo Fisher Scientific | 456.66 | premium content | ||
UHS | Universal Health Services | 137.94 | premium content | ||
UNH | UnitedHealth Group Incorp | 332.21 | premium content | ||
VAR | Varian Medical Systems, I | 175.80 | n/a | n/a | n/a |
VRTX | Vertex Pharmaceuticals In | 217.04 | premium content | ||
WAT | Waters Corporation | 279.90 | premium content | ||
XRAY | DENTSPLY SIRONA Inc. | 54.00 | premium content | ||
ZBH | Zimmer Biomet Holdings, I | 163.69 | premium content | ||
ZTS | Zoetis Inc. | 159.05 | premium content |